This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Geron's CEO Presents At Update On Imetelstat Clinical Development Program Conference (Transcript)

Geron Corporation (GERN)

Update on Imetelstat Clinical Development Program Conference Call

September 10, 2012 8:30 am ET


Anna Krassowska – Investor and Media Relations

John A. Scarlett – President and Chief Executive Officer

Stephen M. Kelsey – Executive Vice President, Head of Research & Development and Chief Medical Officer

Graham K. Cooper – Executive Vice President, Finance and Business Development and Chief Financial Officer


Karen E. Jay – JPMorgan Chase & Co.

Brian Klein – Stifel Nicolaus & Company, Inc.

Charles Duncan – JMP Securities

Ryan Martin – Lazard Capital Markets



Good day, ladies and gentlemen, and welcome to the Geron’s Conference Call to provide update on Imetelstat Clinical Development Program. My name is Ann and I will be your coordinator for today’s call. At this time, all participants are in listen-only mode. (Operator Instructions) We will be facilitating a question-and-answer session following the presentation.

I would now like to turn the presentation over to your host for today’s call, Anna Krassowska, Investor and Media Relations. Please proceed.

Anna Krassowska

Thank you, Ann. Good morning everyone, and thank you for joining us to hear this update on our clinical development program for imetelstat. With me on the call this morning are Dr. John Scarlett, President and Chief Executive Officer; Dr. Steve Kelsey, Executive Vice President, Head of R&D and Chief Medical Officer; and Graham Cooper, Executive Vice President, Finance and Business Development and Chief Financial Officer.

Following our remarks, we will take questions. The press release issued this morning provided an update on the imetelstat program is available on our website at Today’s call is being webcast live on Geron’s website and will be available for replay until October 10.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs